Akouos

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Akouos and buy or sell other stocks, options, and ETFs commission-free!

About AKUS

Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner. 

CEO
Emmanuel J. Simons, PhD, MBA
CEOEmmanuel J. Simons, PhD, MBA
Employees
Employees
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2016
Founded2016
Employees
Employees

AKUS Key Statistics

Market cap
491.02M
Market cap491.02M
Price-Earnings ratio
-5.06
Price-Earnings ratio-5.06
Dividend yield
Dividend yield
Average volume
854.20K
Average volume854.20K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$13.60
52 Week high$13.60
52 Week low
$2.32
52 Week low$2.32
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.